Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.
Position in QURE — uniQure N.V.
CIK 2011081
WARSZAWA, R9
Position in QURE
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$8,529,418
-$3,954,312 QoQ
Shares Held
521,677
0.0% QoQ
Ownership
0.827%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in QURE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds $261,074,012 across 8 Biotechnology names. QURE ranks #6 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
765,915 | $85,284,635 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
571,825 | $60,270,355 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
479,080 | $46,590,530 | |
| 4 | CYTK |
Cytokinetics Inc
|
660,310 | $43,521,032 | |
| 5 | NKTR |
Nektar Therapeutics
|
122,326 | $8,801,355 | |
| 6 | QURE |
uniQure N.V.
This page
|
521,677 | $8,529,418 | |
| 7 | JANX |
Janux Therapeutics, Inc.
|
376,496 | $5,233,294 | |
| 8 | MLYS |
Mineralys Therapeutics, Inc.
|
104,961 | $2,843,393 |
All Filings in QURE
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,529,418 | 521,677 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $12,483,730 | 521,677 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $30,450,286 | 521,677 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||